Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study.

Autor: Richards, Donald, Kuefler, Paul, Becerra, Carlos, Wilfong, Lalan, Gersh, Robert, Boehm, Kristi, Zhan, Feng, Asmar, Lina, Myrand, Scott, Hozak, Rebecca, Zhao, Luping, Gill, John, Mullaney, Brian, Obasaju, Coleman, Nicol, Steven
Zdroj: Investigational New Drugs; Feb2011, Vol. 29 Issue 1, p144-153, 10p
Databáze: Complementary Index
Externí odkaz: